Scientech Research »

Ultragenyx Pharmaceutical shares owned by Scientech Research

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Scientech Research

Quarter filed Position value Share count Share price at filing
2025-09-30 $942k 31k 30.08
2025-06-30 $223k 6.1k 36.36

More positions owned by Scientech Research

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Applovin Corp Com Cl A (APP)
Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Alnylam Pharmaceuticals (ALNY)
Tilray (TLRY)
Uniqure Nv SHS (QURE)
Mongodb Cl A (MDB)
Insulet Corporation (PODD)
Transocean Registered Shs (RIG)
Zebra Technologies Corporati Cl A (ZBRA)
Robinhood Mkts Com Cl A (HOOD)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)
Adobe Systems Incorporated (ADBE)

View all positions for Scientech Research

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
Jpmorgan Chase & Co
Sands Capital Management
State Street Corporation
Rtw Investments
Baker Bros. Advisors
Jacobs Levy Equity Management
Suvretta Capital Management
Wellington Management Company
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Bnp Paribas Investment Partners
Pictet Asset Management Holding SA

View all funds holding Ultragenyx Pharmaceutical